Welcome to Prolieve® Thermodilatation™ System!
Prolieve® is the Only TransUrethral ThermoDilatation™ (TUTD) with a Patented Dilating Balloon that significantly minimizes Patient Discomfort, Post-Treatment Catheterization and offers Immediate Symptomatic Relief compared to other Minimally-Invasive BPH therapies. Over 100,000 cases have been performed in the U.S. alone. 5-year FDA Follow-up Study demonstrated Long-Term Safety, Efficacy and Durability with improved LUTS, Peak Flow Rate, Quality of Life, and little/no Sexual Side Effects. The data also suggest Prevention of BPH Progression with Stabilization of serum PSA and Prostate Size over time. Prolieve® therapy is a safe, 45-minute In-Office procedure performed under Local Anesthesia, thus should be considered First-Line Treatment of Choice among Symptomatic BPH patients. Its other clinical advantages include No Sloughing, No Puncture of the Prostate to avoid Post-Treatment Hemorrhage/Catheterization, and No Foreign Body Implants left within the urinary tract. Prolieve® TUTD remains one of The Highest Reimbursed (CPT code 53850) office-based urological procedures on the market.
Brands: Prolieve® ThermoDilatation™ (TUTD) System